Divalent metal cations increase the activity of the antimicrobial peptide kappacin

Antimicrobial Agents and Chemotherapy

Volumn 49, Issue 6, 2005, Pages 2322-2328

  Dashper, Stuart G ^a   O'Brien Simpson, Neil M ^a   Cross, Keith J ^a   Paolini, Rita A ^a   Hoffmann, Brigitte ^a   Catmull, Deanne V ^a   Malkoski, Marina ^a   Reynolds, Eric C ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; DIVALENT CATION; KAPPA CASEIN; KAPPA CASEIN A; KAPPACIN A; KAPPACIN B; POLYPEPTIDE ANTIBIOTIC AGENT; TRIFLUOROETHANOL; UNCLASSIFIED DRUG; ZINC CHLORIDE; ZINC ION;

ACIDITY; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL METABOLISM; BACTERIUM CULTURE; BIOFILM; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DRUG STRUCTURE; DRUG SYNTHESIS; METAL BINDING; MILK; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH MEASUREMENT; PRIORITY JOURNAL; STREPTOCOCCUS MUTANS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; BIOFILMS; CALCIUM; CASEINS; CATIONS, DIVALENT; COLONY COUNT, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; STREPTOCOCCUS MUTANS; STRUCTURE-ACTIVITY RELATIONSHIP; ZINC;

EID: 19544377989     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.49.6.2322-2328.2005     Document Type: Article

References (35)

1. Aguilera, O., L. M. Quiros, and J. F. Fierro. 2003. Transferrins selectively cause ion efflux through bacterial and artificial membranes. FEBS Lett. 548:5-10.
2. Belli, W. A., and R. E. Marquis. 1991. Adaptation of Streptococcus mutans and Enterococcus hirae to acid stress in continuous culture. Appl. Environ. Microbiol. 57:1134-1138.
3. Boman, H. G. 1991. Antibacterial peptides: key components needed in immunity. Cell 65:205-207.
4. Costerton, J. W., Z. Lewandowski, D. E. Caldwell, D. R. Korber, and H. M. Lappin-Scott. 1995. Microbial biofilms. Annu. Rev. Microbiol. 49:711-745.
5. Creamer, L., and D. Harris. 1997. Relationship between milk protein polymorphism and physico-chemical properties. Milk Protein Polymorphism Special Issue 9702:110-123.
6. Cummins, D. 1991. Zinc citrate/Triclosan: a new antiplaque system for the control of plaque and the prevention of gingivitis: short-term clinical and mode of action studies. J. Clin. Periodontol. 18:455-461.
7. Dashper, S. G., and E. C. Reynolds. 1990. Characterization of transmembrane movement of glucose and glucose analogs in Streptococcus mutants Ingbritt. J. Bacteriol. 172:556-563.
8. Epand, R. M., and H. J. Vogel. 1999. Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462:11-28.
9. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:497-509.
10. Goumon, Y., K. Lugardon, B. Kieffer, J. F. Lefevre, A. Van Dorsselaer, D. Aunis, and M. H. Metz-Boutigue. 1998. Characterization of antibacterial COOH-terminal proenkephalin-A-derived peptides (PEAP) in infectious fluids. Importance of enkelytin, the antibacterial PEAP209-237 secreted by stimulated chromaffin cells. J. Biol. Chem. 273:29847-29856.
11. Goumon, Y., J. M. Strub, M. Moniatte, G. Nullans, L. Poteur, P. Hubert, A. Van Dorsselaer, D. Aunis, and M. H. Metz-Boutigue. 1996. The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity. Eur. J. Biochem. 235:516-525.
12. 2 on glycolysis in human oral microbes. Arch. Oral Biol. 47:117-129.
13. Hope, C. K., and M. Wilson. 2003. Measuring the thickness of an outer layer of viable bacteria in an oral biofilm by viability mapping. J. Microbiol. Methods 54:403-410.
14. 1H NMR spectroscopy. J. Biol. Chem. 273:33517-33523.
15. Malkoski, M., S. G. Dashper, N. M. O'Brien-Simpson, G. H. Talbo, M. Macris, K. J. Cross, and E. C. Reynolds. 2001. Kappacin, a novel antibacterial peptide from bovine milk. Antimicrob. Agents Chemother. 45:2309-2315.
16. Marsh, P. D. 2003. Plaque as a biofilm: pharmacological principles of drug delivery and action in the sub- and supragingival environment. Oral Dis. 9(Suppl. 1):16-22.
17. Martin, E., T. Ganz, and R. I. Lehrer. 1995. Defensins and other endogenous peptide antibiotics of vertebrates. J. Leukoc. Biol. 58:128-136.
18. Matsuzaki, K., O. Murase, H. Tokuda, S. Funakoshi, N. Fujii, and K. Mivajima. 1994. Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry 33:3342-3349.
19. Merrifield, R. B., E. L. Merrifield, P. Juvvadi, D. Andreu, and H. G. Boman. 1994. Design and synthesis of antimicrobial peptides. Ciba Found. Symp. 186:5-26.
20. Nikaido, H., K. Nikaido, and S. Harayama. 1991. Identification and characterization of porins in Pseudomonas aeruginosa. J. Biol. Chem. 266:770-779.
21. Park, Y., D. G. Lee, S. H. Jang, E. R. Woo, H. G. Jeong, C. H. Choi, and K. S. Hahm. 2003. A Leu-Lys-rich antimicrobial peptide: activity and mechanism. Biochim. Biophys. Acta 1645:172-182.
22. Phan, T. N., T. Buckner, J. Sheng, J. D. Baldeck, and R. E. Marquis. 2004. Physiologic actions of zinc related to inhibition of acid and alkali production by oral streptococci in suspensions and biofilms. Oral Microbiol. Immunol. 19:31-38.
23. Pisano, A., N. Packer, J. Redmond, K. Williams, and A. Gooley. 1994. Characterization of O-linked glycosylation motifs in the glycopeptide domain of bovine kappa-casein. Glycobiology 4:837-844.
24. a.Plowman, J. E., L. K. Creamer, M. J. Liddell, and J. J. Cross. 1997. Solution conformation of a peptide corresponding to bovine kappa-casein B residues 130-153 by circular dichroism spectroscopy and 1H-nuclear magnetic resonance spectroscopy. J. Dairy Res. 64:377-397.
25. Rinaldi, A. C., M. L. Mangoni, A. Rufo, C. Luzi, D. Barra, H. Zhao, P. K. Kinnunen, A. Bozzi, A. Di Giulio, and M. Simmaco. 2002. Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem. J. 368:91-100.
26. Saito, T., and T. Itoh. 1992. Variations and distributions of O-glycosidically linked sugar chains in bovine κ-casein. J. Dairy Sci. 75:1768-1774.
27. Schroder, J. M. 1999. Epithelial peptide antibiotics. Biochem. Pharmacol. 57:121-134.
28. Shu, M., C. M. Browngardt, Y. Y. Chen, and R. A. Burne. 2003. Role of urease enzymes in stability of a 10-species oral biofilm consortium cultivated in a constant-depth film fermenter. Infect. Immun. 71:7188-7192.
29. Smallcombe, S., S. Patt, and P. Keifer. 1995. WET solvent suppression and its applications to LC NMR and high-resolution NMR spectroscopy. J. Magn. Reson. A 117:295-303.
30. a.Smith, M. H., P. J. Edwards, K. P. Palmano, and L. K. Creamer. 2002. Structural features of bovine caseinomacropeptide A and B by 1H nuclear magnetic resonance spectroscopy. J. Dairy Res. 69:85-94.
31. Strub, J. M., Y. Goumon, K. Lugardon, C. Capon, M. Lopez, M. Moniatte, A. Van Dorsselaer, D. Aunis, and M. H. Metz-Boutigue. 1996. Antibacterial activity of glycosylated and phosphorylated chromogranin A-derived peptide 173-194 from bovine adrenal medullary chromaffin granules. J. Biol. Chem. 271:28533-28540.
32. Svensater, G., J. Welin, J. C. Wilkins, D. Beighton, and I. R. Hamilton. 2001. Protein expression by planktonic and biofilm cells of Streptococcus mutans. FEMS Microbiol. Lett. 205:139-146.
33. Talbo, G. H., D. Suckau, M. Malkoski, and E. C. Reynolds. 2001. MALDI-PSD-MS analysis of the phosphorylation sites of caseinomacropeptide. Peptides 22:1093-1098.
34. Wilson, M. 1996. Susceptibility of oral bacterial biofilms to antimicrobial agents. J. Med. Microbiol. 44:79-87.
35. Wimpenny, J., A. Peters, and M. Seoul-field. 1989. Modeling spatial gradients, p. 111-127. In W. Characklis and P. Widerer (ed.), Structure and function of biofilms. John Wiley and Sons, Chichester, England.